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the research has since produced crucial
fundamental insights. As researchers zero
in on the specific amino-acid sequences
that bind with integrins, he says, they've
developed a molecular probe for better
understanding communication between
cells. "When that information transfer
becomes dysfunctional," he notes, "it can
induce disease states."
Bird Flu Vaccine
In the race to develop vaccines against an
ever-widening array of infectious diseases,
Aviron, a biopharmaceutical research and
development company located in
Mountain View, California, may be lead-
ing by a nose. Working in collaboration
with the National Institutes ofHealth and
the Centers for Disease Control and
Prevention, Aviron is developing a novel
technology in antiviral vaccinations: the
cold-adapted live influenza vaccine. A
major advantage of the new technology is
that the vaccine may be administered
through a nasal spray, bypassing the need
for injections. Currently, Aviron is using
its technology to develop two candidate
vaccines against the avian A/Hong
Kong/97 (H5N1) influenza virus, more
commonlyknown as the "bird flu."
The bird flu, which first appeared in
humans in May 1997, is the latest in a
string ofwhat are known as "Hong Kong
flu" epidemics-outbreaks that start in
southeast China, where the densely packed
population lives cheek to beak with large
numbers of chickens, ducks, and other
poultry. It is believed that the birds carry
various viral strains that are then transmit-
ted somehow-perhaps through pig inter-
mediaries-to humans. Scientists aren't
sure why or how the viruses cross over to
humans, but the results in the past have
been devastating, as evidenced by out-
breaks such as one in 1968 that killed
thousands worldwide. In December, Hong
Kong officials launched what appears to
have been a successful strike against the
disease by slaughtering over 1 million
chickens and otherpoultry.
Martin Bryant, vice president of
research for Aviron, says, "With the elimi-
nation ofthe Hong Kong poultry popula-
tion, the epidemic was aborted; the virus
never got up the steam to pass from one
person to another. What happens is that a
virus may be modified as it passes from
person to person, and that did not occur.`
Still, says Bryant, although the bird flu
didn't spread to epidemic proportions this
time, it's not a matter ofwhether such an
epidemic will come, but when-and pub-
lic health officials should be prepared.
Friend or fowl? A new vaccine technology may
prevent outbreaks of the avian A/Hong Kong/97
influenza virus, or 'bird flu," which has recently
begun to appear in humans.
Aviron scientists are using a "reverse
genetics," or recombinant, approach to
introduce specific protective genes into an
attenuated (weakened) master donor virus
strain from which all flu vaccines are devel-
oped. The vaccine could also be used as a
platform to prepare an inactivated version
ofthevaccine in large quantities.
Aviron's live-virus vaccines are attenu-
ated viruses that are adapted to grow in the
relatively cool nasal region as well as in the
lungs. The cold-adapted flu virus triggers
an immune response at the place of entry
of the influenza virus, leaving the vaccine
recipient free of flu but armed with
immune capabilities to combat future
attacks by thevirus.
Exposure to the flu is believed to occur
largely through inhalation ofdroplets con-
taining the live virus, and some view the
nasal spray asworking directly at the site of
infection. In a 1997 trial of 1,602 children
aged six years and younger, the nasal spray
vaccine showed an amazing 93% efficacy
rate against culture-confirmed influenza.
This efficacy rate may be due to the fact
that spraying the vaccine in the nose stim-
ulates the mucosal antibodies found in the
nose, throat, and mouth, and circulating
antibodies in the bloodstream. These anti-
bodies are an added boost to the cell-medi-
ated immune responses triggered by the
traditional flu shot.
The absence of needles is seen as an
advantage in getting the vaccine to people
who are afraid of shots, particularly chil-
dren, who are one ofthe primaryvectors of
influenza. Says Bryant, "The first wave of
anyepidemic in acommunity usually starts
with kids." Plus, because it's a simple nose-
spray, the vaccine wouldn't need to be
administered by a health-care professional.
Eventually, the vaccine may even be avail-
able overthe counter.
The Aviron live-virus vaccine is cur-
rently undergoing late Phase III trials. The
company hopes to present its product for
license review by the Food and Drug
Administration by mid-1998. Although a
bird flu epidemic appears to have been
temporarily staved off, Bryant says, "We
may not use it this time, but there will be a
time when we will. We are working hard
to be ready before it comes."
The State of the Science on
Endocrine Disruptors
As research on endocrine-disrupting chemi-
cals flourishes worldwide, international
groups are working to coordinate research
activities being conducted by organizations
around the globe. The International
Programme on Chemical Safety (IPCS), a
collaborative program ofthe World Health
Organization (WHO), the International
Labour Organization, and the United
Nations Environment Programme, is lead-
ing an effort to conduct a global inventory
ofongoing research activities related to the
health and ecological effects of endocrine-
disrupting chemicals, and is working to
develop an international assessment of the
state ofthe science on endocrine disruptors.
The Organisation for Economic Co-opera-
tion and Development (OECD) is leading
international efforts on delineating testing
methods for endocrine disruptors.
On 16-18 March 1998, the IPCS, in
coordination with the OECD, convened a
joint meeting in Washington, DC, with a
steering committee of scientific experts to
provide guidance for these projects. The
steering group was made up ofrepresenta-
tives from Canada, Finland, Germany,
Italy, Sweden, the Netherlands, Mexico,
Japan, the United Kingdom, and the
United States. The objectives of the meet-
ing were to discuss the structure and con-
tent of the global inventory and to define
the objectives and scope ofthe internation-
al state ofthe science assessment document,
as well as develop an oudine and guidelines
fordevelopment ofthe document.
Participants wereasked todiscuss awork-
ing definition for endocrine-disrupting
chemicals, and it was agreed to define an
endocrine disruptor as an exogenous sub-
stance or mixture that alters the function of
the endocrine system and consequently caus-
esadversehealth effects in an intact organism
or its progeny or subpopulations. Apotential
endocrine disruptor is defined as an exoge-
nous substance or mixture that possesses
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properties that might be expected to lead to
endocrine disruption in an intact organism
orits progenyorsubpopulations.
The global inventory of research on
endocrine disruptors is intended to serve as
a communications tool, providing infor-
mation exchange among scientists world-
wide. This will allow for the examination
ofcurrent research efforts, and aid in iden-
tifying research gaps and developing strate-
gies to address such gaps. The steering
committee was asked to address four main
issues concerning the inventory-structure
and. content of the
inventory, criteria for
inclusion of research
projects, a communica-
tions strategy, and a
timetable and oversight
for the inventory.
The global inventory
will be built on ongoing
inventory efforts in the
United States, Canada,
and the European
Union. The steering
committee determined
that the top priority in
developing the inventory
should be to integrate
existing databases from
these three sources into a
single on-line database,
which will be available
to researchers worldwide
as well as to the general
public. The integration
of the database is being
coordinated by the U.S.
EPA. Robert Kavlock,
skeodrinput
* will bepublished as apeer-reviewed
WHO document (notintended as a
risk assessment or consensus
document)
director ofthe reproductive toxicology divi-
sion ofthe EPA, says he and others are now
in "data collection mode" and are working
to update and combine databases from both
government and nongovernmental organiza-
tions. Kavlock says the database will be use-
ful for funding organizations to ensure that
research they support is complementary to
other research efforts, and to individual
investigators in identifying others around the
world with common research interests.
Kavlock says he is optimistic that the data-
base will be completed by the end of this
year. The current U.S. database is available
on line at http://www.epa.gov/endocrine.
The IPCS is simultaneously working
to develop a state ofthe science assessment
report. The steering committee members
discussed the objectives ofthe report, and
determined that the document is intended
to build on existing assessment docu-
ments-including what is known about
the health and ecological effects of
endocrine disruptors-and identify what
uncertainties remain. The document is
intended to help direct future research on
endocrine disruptors. The committee
members stressed that the document will
focus on science and not on risk assess-
ment. They also noted that the document
will emphasize global issues, such as trans-
boundary migration of environmental
contaminants.
The committee members also discussed
the development process of the document.
The process will provide opportunities for
multisectorial input, and will also include
rigorous international
peer review. The doc-
ument will require
the participation of
approximately 25
authors, according to
Terri Damstra, team
leader of the
WHO/IPCS Inter-
regional Research
Unit, who is the
responsible IPCS
officer overseeing the
project. Damstra says
the steering commit-
tee is now working to
select potential
authors, who will be
chosen on the basis of
scientific expertise.
The committee has
developed a prelimi-
nary outline, which
will be expanded
upon by prospective
authors in the next
few months.
The steering committee noted that,
although the first meeting was limited to
scientific experts, the future process will be
open to the public and include input from
multiple interests. The final document will
be published as a WHO document that
organizers hope will be available in the
spring of2000.
Landfills: Is Wetter Better?
Over the past 30 years, garbage landfill
designers have gone to great lengths to halt
groundwater pollution. In a well-designed
modern landfill, caps keep water out, liners
and liquid removal systems control any
water that does enter, and groundwater
pollution is not a significant problem. But
new landfills are so dry that garbage can
take many decades to decompose. That
may be too long, according to Robert
Ham, professor emeritus of civil and envi-
ronmental engineering at the University of
Wisconsin at Madison, and author ofa new
study on landfill decomposition that has
been accepted for publication in theJournal
ofEnvironmentalEngineering.
At intervals of one, two, and six years
after placing bags of waste in landfills in
Florida, Pennsylvania, and Wisconsin,
Ham and his colleagues exhumed the bags
and weighed the garbage that remained.
They found that most food items had
degraded significantly, with faster decay
occurring in moister conditions.
Newspaper, however, was the most decay-
resistant of all the materials tested-even
more so than disposable diapers. In a dry,
well-capped Wisconsin landfill, newspaper
lost only 5.6% ofits dryweight in six years.
But in a Florida landfill that lacked the clay
cap that is required on new landfills, news-
paper lost 7.4% of its weight in the first
year, and 17% by the second year (the six-
year samples could not be located in
Florida). Ham says the study shows that
garbage does degrade in a dry, modern
landfill, but that it degrades much faster
when moisture is present. Thus, Ham calls
moisture the "master variable" in the
decomposition rate.
The rate of decomposition has been
largely ignored in the quest for safer land-
fills. But Ham says faster decomposition is
better, because landfills produce the highest
concentrations of various substances in
toxic leachate (water that contains dissolved
chemicals from the garbage) and the green-
house gas methane while the garbage is
actively decomposing. When anaerobic
bacteria devour garbage, they produce
methane, which is often recovered from
landfills and burned to generate electricity.
Ham says rapid decomposition would raise
the rate of methane generation, improving
the economics for recovery and, thus,
reducing emissions to the atmosphere.
The present policy ofdry landfills may
be good for groundwater, Ham says, but it
is "causing problems over the long haul by
postponing decomposition until years after
the waste is emplaced." He expects that
decay could take as long as 50 years in
modern landfills.
Instead of the "dry tomb" approach
described above, Ham advocates building
"bioreactors" where decomposition would
be accelerated. The idea interests some
landfill operators. "It's very important for
financial reasons," says Martin Felker, man-
ager of landfill engineering at Waste
Management, a garbage hauling corpora-
tion based in Oakbrook, Illinois. The faster
the waste degrades, Felker notes, the more
waste will fit in a particular site.
Furthermore, rapid degradation could also
reduce the duration ofmonitoring ground-
water and methane around landfills.
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